Search

everythinglearnresearchcommunity

for

Search:↓

Oral minoxidil may be a better treatment for hair loss than topical minoxidil.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Sarcoidosis can mimic other skin disorders, making diagnosis challenging.

Sodium valproate can cause reversible hair loss in some patients.

COVID-19 infection can significantly cause temporary hair loss.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Monocytes might be linked to hair loss after COVID-19.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

COVID-19 may cause temporary hair loss in some people.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.

Cellcurin therapy with microneedling increases hair density and thickness in treating hair loss in men and women.

More personalized and effective treatments for androgenetic alopecia are needed.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Treating hair loss in both men and women is effective and improves quality of life.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Guava leaf extract may help treat hair loss and protect cells by blocking certain genes and fighting damaging molecules.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.